PDE4A and psoriasis vulgaris: Inhibition of PDE-4 decreases the expression of pro-inflammatory cytokines implicated in the pathogenesis of plaque psoriasis, such as TNF-⍺, interferon (IFN)-y, IL-2, IL-12, and IL-23 [17].